Alteration of Thyroid Function Tests and Evaluation of Serum Zinc, IgG and IgM Levels in non-hospitalized Iraqi Patients with Corona Virus
DOI:
https://doi.org/10.37506/rtgtyv61Keywords:
Keywords:Corona Virus, zinc, thyroid function tests, IgG, IgM.Abstract
Background:SARS-CoV-2 is a novel corona virus that would be responsible for COVID-19 infection and has provoked a worldwide epidemic. Objective: To investigate alteration of thyroid function tests and evaluation of serum zinc, IgG and IgM levels in Iraqi patients with corona virus.Methods:A total of 166 sera, 83 from non-hospitalized asymptomatic patients
diagnosed with COVID-19 (aged 17–78 years) and 83(aged 18–70 years) from negative healthy individuals, were evaluated for thyroid hormones T 3 ,T 4 and TSH, trace element of zinc, IgM and IgG antibodies.Results: recent study described non-hospitalized COVID-19 patients who developed argumentative results related to thyroid function test, signs of hypozincemia,
disturbances in IgG, and IgM levels were started in some of them as compared with healthy group. Conclusion:current study discovered that non-hospitalized patients diagnosed with COVID-19 can develop a non-critical state of thyroid function.
References
Wu C, Chen X, Cai Y, Xai J, Zhou X, Xu S. Risk factors associated with acute
respiratory distress syndrome and death in patients with coronavirus disease 2019
pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-43.
doi:10.1001/jamainternmed.2020.09.
2. Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D, Zhoua L, Wanga M, Zhaod Y,
Zengc W, Huange Q, Xub H, Liua Z, GuoL. Clinical characteristics of laboratory-
confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective
single-center analysis. Travel Med Infect Dis. 2020;36. doi:10.1016/j.tmaid.2020.101606.
3. Xiajun L, Albert JL, Bin D. COVID-19, stem cell research. Stem Cell Res.
2021;55:102468. https://doi.org/10.1016/j.scr.2021.102468.
4. Hu T, Liu Y, Zhao M, Zhuang Q, Xu L, He Q. A comparison of COVID-19, SARS, and
MERS. PeerJ. 2020;8 . doi:10.7717/peerj.9725. PMID: 32879801.
5. El Baz S, El Hidan MA, Zouhairi N, Aimrane A, Chatoui R, Echchakery M. Handbook
of research on pathophysiology and strategies for the management of COVID-19.
Chapter 1, COVID-19: The pandemic. Hershey (PA): IGI Global; 2020. p. 16. DOI:
10.4018/978-1-7998-8225-1.ch001.
6. Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine.
2020:1-4. https://doi.org/10.1007/s12020-020-02364-8.
7. Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what
happens to the thyroid and adrenal glands? J Endocrinol Invest. 2020:1-2.
https://doi.org/10.1007/s40618-020-01311-8.
8. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J
Endocrinol Invest. 2020:1-5. https://doi.org/10.1007/s40618-020-01276-8.
9. Parolin M, Parisotto M, Zanchetta F, Sartorato P, De Menis E. Coronaviruses and
endocrine system: a systematic review on evidences and shadows. Endocr Metab Immune
Disord Drug Targets. 2020. https://doi.org/10.2174/1871530320666200905123332.
10. Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the
COVID-19 pandemic. Rev Endocr Metab Disord. 2020;21(4):495-507.
https://doi.org/10.1007/s11154-020-09569-2.
11. Yasui Y, Yasui H, Suzuki K, Saitou T, Yamamoto Y, Ishizaka T, Nishida K, Yoshihara
S, Gohma I, Ogawa Y. Analysis of the predictive factors for a critical illness of COVID-
19 during treatment – relationship between serum zinc level and critical illness of
COVID-19. Int J Infect Dis. 2020;100:230-6. doi:10.1016/j.ijid.2020.09.008.
12. Gonçalves TJM, Gonçalves SEAB, Guarnieri A, Risegato RC, Guimarães MP, de Freitas
DC, Razuk-Filho A, Junior PBB, Parrillo EF. Association between low zinc levels and
severity of acute respiratory distress syndrome by new coronavirus (SARS-CoV-2). Nutr
Clin Pract. 2021;36:186-91. doi:10.1002/ncp.10612.
13. Chen S, Meng L, Wang L, Huang X, Ali S, Chen X, Yu M, Yi M, Liu L, Chen X, Yuan
L, Shi W, Huang G. SERS-based lateral flow immunoassay for sensitive and
simultaneous detection of anti-SARS-CoV-2 IgM and IgG antibodies by using gap-
enhanced Raman nanotags. Sens Actuators B Chem. 2021;348:130706.
doi:10.1016/j.snb.2021.130706.
14. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan
JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is
a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-4.
https://doi.org/10.1038/nature02145.
15. Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, Ge Q, Zhu J, Zhou X. Thyroid
hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol
Invest. 2020. doi:10.1007/s40618-020-01460-w.
16. Trimboli P, Camponovo C, Scappaticcio L, Bellastella G, Piccardo A, Rotondi M.
Thyroid sequelae of COVID-19: a systematic review of reviews. Rev Endocr Metab
Disord. 2021;22(2):485-91. doi:10.1007/s11154-021-09653-1.
17. Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients.
Lancet Diabetes Endocrinol. 2015;3(10):816-25. doi:10.1016/s2213-8587(15)00225-9.
18. Mebis L, Debaveye Y, Visser TJ, Van den Berghe G. Changes within the thyroid axis
during the course of critical illness. Endocrinol Metab Clin North Am. 2006;35(4):807-
21. doi:10.1016/j.ecl.2006.09.009.
19. Ko JH, Muller MA, Seok H, Park GE, Lee JY, Cho SY, Ha YE, Baek JY, Kim SH, Kang
JM, Kim YJ, Jo IJ, Chung CR, Hahn MJ, Drosten C, Kang CI, Chung DR, Song JH,
Kang ES, Peck KR. Suggested new breakpoints of anti-MERS-CoV antibody ELISA
titers: performance analysis of serologic tests. Eur J Clin Microbiol Infect Dis.
2017;36(11):2179-86. doi:10.1007/s10096-017-3043-3.
20. Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Kao RY, Chan KH, Peiris JS, Yuen
KY. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus
spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus
nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin
Microbiol. 2005;43(7):3054-8. doi:10.1128/jcm.43.7.3054-3058.2005.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Ownership: Authors retain copyright ownership of their work after publication in IJOP. However, they grant the journal an exclusive Creative Commons license.
Creative Commons License: The authors grant IJOP the right to exclusively apply a Creative Commons license to their work upon publication. This license permits use, distribution, and reproduction of the work in any medium, provided that the original work and its source are properly cited. The specific license applied is Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which allows for attribution, non-commercial use, and derivative works.
Editorial Research: Authors grant the journal the right to analyze information obtained from submitted manuscripts for editorial research purposes. This analysis aims to improve the peer-review process, teaching, and training activities.
Warranties: Authors warrant that their work is original, contains no libelous statements, is lawful, and does not infringe upon any copyright, trademark, patent, or proprietary rights of others. Authors agree to indemnify the editors against any costs, expenses, and damages arising from any breach of this warranty.
Views and Opinions: The views and opinions expressed in the article are those of the authors and not necessarily those of the journal.